Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.
about
Current endoscopic methods of radical therapy in early esophageal cancerInvolved-field radiotherapy for esophageal squamous cell carcinoma: theory and practiceProspective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma.Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer.Effect of dose-escalation of 5-fluorouracil on circadian variability of its pharmacokinetics in Japanese patients with Stage III/IVa esophageal squamous cell carcinomaSurvival comparison between radical surgery and definitive chemoradiation in 267 esophageal squamous cell carcinomas in a single institution: A propensity-matched study.Phase II study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed and cisplatin for locally advanced oesophageal squamous cell carcinoma.Artificially induced epithelial-mesenchymal transition in surgical subjects: its implications in clinical and basic cancer research.TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.Effects of photodynamic therapy for superficial esophageal squamous cell carcinoma in vivo and in vitro.Surgical treatments for esophageal cancers.Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.Assessment of myocardial metabolic disorder associated with mediastinal radiotherapy for esophageal cancer -a pilot study.Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis.Long-term results of chemoradiotherapy for stage II-III thoracic esophageal cancer in a single institution after 2000 -with a focus on comparison of three protocolsDiscovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by ChemoradiotherapyInvolved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study.Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer.Predictive factors for pericardial effusion identified by heart dose-volume histogram analysis in oesophageal cancer patients treated with chemoradiotherapyA comparative dosimetric study of left sided breast cancer after breast-conserving surgery treated with VMAT and IMRT.Predictive factors for radiation pneumonitis in oesophageal cancer patients treated with chemoradiotherapy without prophylactic nodal irradiation.Increased serum cell-free DNA levels in relation to inflammation are predictive of distant metastasis of esophageal squamous cell carcinomaVEGF -634C/G genotype is predictive of long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinomaClinical results of proton beam therapy for twenty older patients with esophageal cancer.Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinomaFrequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma.Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I-III esophageal cancer.Treatment of thoracic esophageal carcinoma invading adjacent structures.Acute effects of chemoradiation on cardiac function in oesophageal cancer: a MUGA scan and echo-based study.Involved-field irradiation in definitive chemoradiotherapy for T4 squamous cell carcinoma of the esophagusDetails of out-field regional recurrence after involved-field irradiation with concurrent chemotherapy for locally advanced esophageal squamous cell carcinomaImmunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation.Definitive chemoradiotherapy with capecitabine and cisplatin in patients with esophageal cancer: a pilot studyEvaluation of radiation-induced myocardial damage using iodine-123 β-methyl-iodophenyl pentadecanoic acid scintigraphy.Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitroNeoadjuvant hyperfractionated-accelerated radiotherapy with concomitant chemotherapy in esophageal cancer: phase II study.Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.Retrospective review of surgery and definitive chemoradiotherapy in patients with squamous cell carcinoma of the thoracic esophagus aged 75 years or older.
P2860
Q26860714-74C404B4-8670-4AE8-AF2F-DB562CEEDEF6Q28073933-96B444D0-7B4B-40F3-BECD-281D67AF349DQ30907567-43C4B7F3-10A8-46EF-8977-989700CB7123Q33424985-1B7027D3-B144-4B36-BB8A-02964393339CQ33429328-F6B9F3BA-A2D9-41DF-BB8C-7474AEFB9CBBQ33591847-E4273C4C-A49D-4AD1-8A7A-FC72A9AA43E6Q33646186-F3E524F0-0DCF-4D0D-A009-87423F7D2DA4Q33653046-8E002052-74FB-41C3-8478-D056C90DDBE6Q33823039-0BCB3C72-737C-4DDD-87FE-3FC3BDC3778DQ33885980-0AD69B9E-D274-42F2-985B-F986DB03104BQ34043755-E54D893F-D272-4CA6-911D-D440F7D131A4Q34410943-991CB29B-21F0-464C-A927-AA789BFB6188Q35256054-93AD92BD-4056-4D4A-8969-7081328DC87CQ35420526-E5461888-790D-432D-BDCF-D8FA7935979AQ35530285-CDD6C677-D9A4-4EDF-A915-419095E4EB85Q35591822-88B71D8A-4146-4DFD-BC0B-2A4F1B82F993Q35823373-F04C8483-133D-4C59-AD4D-E3479E6FB16BQ35857352-7082D504-5987-47DD-A2F2-C8BE8077DC62Q36009957-5DE86871-EDCD-4CA6-90ED-15BAB7A99324Q36074242-141D99DF-1152-40BC-998F-BFB814DF86EDQ36187160-413334DD-BBDC-4685-AD93-D273F07114FDQ36292795-598C8AC0-328D-4C19-BA52-0F0B575F4C78Q36326303-F8D21B21-1674-41BF-91C0-A1B0AC7F60B3Q36375396-75021090-438A-4351-9489-0E7D222ED426Q36400850-7EB68DE1-005E-4197-B3F8-7AB23BAC2FFCQ36490390-BA3BA4F4-D010-4936-8E39-CDAFD5C14B1DQ36611021-336D35CE-CA86-4E7B-9276-F0541F095341Q36616556-EC0E6849-4138-42A9-A341-66FC3103ED16Q36706857-4F460090-E821-4921-8D8D-DC86CAD78F38Q36794837-0EDEBC13-FC00-421A-9483-55261540F567Q36801089-1263B45C-092A-4CFD-8669-1AC59A5C0E41Q36807919-64970B22-B2FD-4678-A7C0-28A04FA2E1B0Q36944123-DC59AD40-F3E8-4D8B-8A42-EEE5E8CF985CQ36985164-072A27AF-35B7-4E09-ADB4-345B564EC734Q37116834-D5BC817A-A43A-4509-B251-625396530222Q37154052-3974FC15-596C-4EA3-AB40-54DDF491D6EEQ37167981-409928A6-26C7-48F6-BC6A-57F304C9527BQ37285962-477D2E60-87D3-45C8-AAEA-7C7F4E66F0F7Q37376917-AA3ED10F-6713-4CA8-AB31-A1E2A198DA12Q37457591-7467C145-83AF-4234-B185-6D2C99263074
P2860
Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Long-term toxicity after defin ...... oma of the thoracic esophagus.
@en
Long-term toxicity after defin ...... oma of the thoracic esophagus.
@nl
type
label
Long-term toxicity after defin ...... oma of the thoracic esophagus.
@en
Long-term toxicity after defin ...... oma of the thoracic esophagus.
@nl
prefLabel
Long-term toxicity after defin ...... oma of the thoracic esophagus.
@en
Long-term toxicity after defin ...... oma of the thoracic esophagus.
@nl
P2093
P356
P1476
Long-term toxicity after defin ...... oma of the thoracic esophagus.
@en
P2093
Atsushi Ohtsu
Keiji Nihei
Kiyomi Mera
Manabu Muto
Narikazu Boku
Satoshi Ishikura
Shigeaki Yoshida
Shuichi Hironaka
Takashi Ogino
P304
P356
10.1200/JCO.2003.03.055
P407
P577
2003-07-01T00:00:00Z